Filing Details

Accession Number:
0001209191-17-012989
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-21 20:22:05
Reporting Period:
2017-02-16
Filing Date:
2017-02-21
Accepted Time:
2017-02-21 20:22:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142750 Amn Healthcare Services Inc AMN Services-Help Supply Services (7363) 061500476
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1320242 L Denise Jackson 12400 High Bluff Drive
San Diego CA 92130
General Counsel / Sr. V.p. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-16 16,287 $0.00 42,652 No 4 A Direct
Common Stock Disposition 2017-02-16 8,498 $38.88 34,154 No 4 F Direct
Common Stock Acquisiton 2017-02-16 2,324 $0.00 36,478 No 4 M Direct
Common Stock Disposition 2017-02-16 1,212 $38.88 35,266 No 4 F Direct
Common Stock Acquisiton 2017-02-16 1,531 $0.00 36,797 No 4 M Direct
Common Stock Disposition 2017-02-16 798 $38.88 35,999 No 4 F Direct
Common Stock Disposition 2017-02-21 823 $40.90 35,176 No 4 S Direct
Common Stock Disposition 2017-02-21 9,634 $41.61 25,542 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2017-02-16 2,324 $0.00 2,324 $0.00
Common Stock Restricted Stock Units Disposition 2017-02-16 1,531 $0.00 1,531 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,256 No 4 M Direct
3,108 No 4 M Direct
Footnotes
  1. The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2014. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2016 for the one-year period beginning on January 1, 2016 and ended December 31, 2016. The maximum amount of PRSUs for this award were deemed earned and vested.
  2. Number of shares withheld for tax purposes.
  3. Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").
  4. Common Stock acquired on the vesting of RSUs.
  5. The sale of 823 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  6. The sale of 9,634 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  7. The price reported in this row represents a weighted average price of $41.609 per share. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  8. The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of Common Stock.
  9. The RSUs identified in this row were granted on January 5, 2015 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2015 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2016 fiscal year.
  10. RSUs do not have an expiration date.
  11. The RSUs identified in this row were granted on January 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2016 fiscal year and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2017 fiscal year.